Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Hospitalist · AURORA, CO · NPI 1942467469
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 977 | 267 |
| Amlodipine Besylate | Amlodipine Besylate | 561 | 156 |
| Gabapentin | Gabapentin | 307 | 71 |
| Lisinopril | Lisinopril | 299 | 75 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 287 | 82 |
| Losartan Potassium | Losartan Potassium | 251 | 73 |
| Furosemide | Furosemide | 218 | 54 |
| Levothyroxine Sodium | Levothyroxine Sodium | 216 | 54 |
| Omeprazole | Omeprazole | 198 | 50 |
| Hydrochlorothiazide | Hydrochlorothiazide | 188 | 58 |
| Carvedilol | Carvedilol | 169 | 46 |
| Metoprolol Succinate | Metoprolol Succinate | 169 | 54 |
| Tamsulosin Hcl | Tamsulosin Hcl | 160 | 55 |
| Valsartan | Valsartan | 144 | 40 |
| Metformin Hcl | Metformin Hcl | 125 | 40 |
| Potassium Chloride | Potassium Chloride | 124 | 30 |
| Fluticasone Propionate | Fluticasone Propionate | 123 | 52 |
| Trazodone Hcl | Trazodone Hcl | 122 | 42 |
| Hydralazine Hcl | Hydralazine Hcl | 119 | 39 |
| Pantoprazole Sodium | Pantoprazole Sodium | 119 | 27 |
| Duloxetine Hcl | Duloxetine Hcl | 116 | 33 |
| Famotidine | Famotidine | 108 | 30 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 107 | 31 |
| Allopurinol | Allopurinol | 101 | 29 |
| Metoprolol Tartrate | Metoprolol Tartrate | 99 | 19 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 98 | 28 |
| Jardiance | Empagliflozin | 96 | 27 |
| Buspirone Hcl | Buspirone Hcl | 94 | 24 |
| Chlorthalidone | Chlorthalidone | 91 | 26 |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 86 | 24 |
| Spironolactone | Spironolactone | 85 | 26 |
| Ozempic | Semaglutide | 84 | 17 |
| Diclofenac Sodium | Diclofenac Sodium | 83 | 20 |
| Clopidogrel | Clopidogrel Bisulfate | 82 | 22 |
| Metformin Hcl Er | Metformin Hcl | 82 | 28 |
| Escitalopram Oxalate | Escitalopram Oxalate | 78 | 26 |
| Montelukast Sodium | Montelukast Sodium | 77 | 24 |
| Eliquis | Apixaban | 76 | 18 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 75 | 19 |
| Breo Ellipta | Fluticasone/Vilanterol | 73 | 19 |
| Pravastatin Sodium | Pravastatin Sodium | 66 | 21 |
| Donepezil Hcl | Donepezil Hcl | 64 | 16 |
| Bupropion Xl | Bupropion Hcl | 63 | 17 |
| Ibuprofen | Ibuprofen | 63 | 23 |
| Meloxicam | Meloxicam | 62 | 17 |
| Fluoxetine Hcl | Fluoxetine Hcl | 61 | 13 |
| Tramadol Hcl | Tramadol Hcl | 61 | 25 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 60 | 14 |
| Alendronate Sodium | Alendronate Sodium | 56 | 17 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 55 | 14 |
| Sertraline Hcl | Sertraline Hcl | 55 | 16 |
| Amitriptyline Hcl | Amitriptyline Hcl | 53 | 11 |
| Glipizide | Glipizide | 53 | 16 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 52 | 18 |
| Minoxidil | Minoxidil | 52 | 14 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 51 | 11 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 50 | 11 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 48 | 17 |
| Ezetimibe | Ezetimibe | 44 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 44 | suppressed |
| Simvastatin | Simvastatin | 42 | 11 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 40 | 13 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 40 | suppressed |
| Celecoxib | Celecoxib | 38 | 16 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 37 | 11 |
| Nifedipine Er | Nifedipine | 37 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 37 | 18 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 36 | 14 |
| Ondansetron Odt | Ondansetron | 35 | suppressed |
| Levetiracetam | Levetiracetam | 34 | suppressed |
| Glipizide Er | Glipizide | 32 | 12 |
| Repatha Sureclick | Evolocumab | 30 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 30 | suppressed |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 29 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 27 | suppressed |
| Baclofen | Baclofen | 26 | suppressed |
| Rybelsus | Semaglutide | 26 | 12 |
| Indomethacin Er | Indomethacin | 25 | suppressed |
| Torsemide | Torsemide | 25 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 25 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 25 | 11 |
| Citalopram Hbr | Citalopram Hydrobromide | 24 | suppressed |
| Finasteride | Finasteride | 24 | suppressed |
| Novolog Flexpen | Insulin Aspart | 24 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 24 | 11 |
| Dicyclomine Hcl | Dicyclomine Hcl | 23 | suppressed |
| Januvia | Sitagliptin Phosphate | 23 | suppressed |
| Prednisone | Prednisone | 23 | 15 |
| Ventolin Hfa | Albuterol Sulfate | 23 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 22 | suppressed |
| Brilinta | Ticagrelor | 21 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 21 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 20 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 20 | suppressed |
| Atenolol | Atenolol | 19 | suppressed |
| Cefdinir | Cefdinir | 19 | 16 |
| Nystatin | Nystatin | 19 | suppressed |
| Trulicity | Dulaglutide | 19 | suppressed |
| Pregabalin | Pregabalin | 18 | suppressed |
| Xarelto | Rivaroxaban | 18 | suppressed |
| Diazepam | Diazepam | 17 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 17 | suppressed |
| Naproxen | Naproxen | 17 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 17 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 16 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 16 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 16 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 15 | suppressed |
| Indomethacin | Indomethacin | 15 | suppressed |
| Mirtazapine | Mirtazapine | 15 | suppressed |
| Nadolol | Nadolol | 15 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 15 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 15 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 15 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 14 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 14 | suppressed |
| Nitroglycerin | Nitroglycerin | 14 | 11 |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 13 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 13 | suppressed |
| Cilostazol | Cilostazol | 13 | suppressed |
| Dantrolene Sodium | Dantrolene Sodium | 13 | suppressed |
| Lactulose | Lactulose | 13 | suppressed |
| Lamotrigine | Lamotrigine | 13 | suppressed |
| Mounjaro | Tirzepatide | 13 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 13 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 13 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 13 | suppressed |
| Wegovy | Semaglutide | 13 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 12 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Entresto | Sacubitril/Valsartan | 12 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 12 | suppressed |
| Lorazepam | Lorazepam | 12 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 11 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 11 | suppressed |
| Synthroid | Levothyroxine Sodium | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error